These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 6151343)
1. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress. Eggertsen R Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343 [TBL] [Abstract][Full Text] [Related]
2. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients. Eggertsen R; Sivertsson R; Andrén L; Hansson L J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension. Eggertsen R; Sivertsson R; Andrén L; Hansson L Acta Med Scand Suppl; 1985; 693():115-20. PubMed ID: 2859739 [TBL] [Abstract][Full Text] [Related]
4. A new molecule with vasodilating and beta-adrenoceptor blocking properties. Abshagen U J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364 [TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. Eggertsen R; Sivertsson R; Andrén L; Hansson L J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280 [TBL] [Abstract][Full Text] [Related]
6. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients. Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377 [TBL] [Abstract][Full Text] [Related]
7. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients. Eggertsen R; Andrén L; Sivertsson R; Hansson L Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128 [TBL] [Abstract][Full Text] [Related]
8. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine. Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303 [TBL] [Abstract][Full Text] [Related]
9. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension. Lund-Johansen P Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538 [TBL] [Abstract][Full Text] [Related]
10. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure. Lund-Johansen P; Omvik P; Nordrehaug JE; White W J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146 [TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Strein K; Sponer G Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054 [TBL] [Abstract][Full Text] [Related]
12. Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers. Eggertsen R; Hansson L Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):411-23. PubMed ID: 2864319 [TBL] [Abstract][Full Text] [Related]
13. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642 [TBL] [Abstract][Full Text] [Related]
14. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance. Morgan T; Snowden R; Butcher L J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol. Wendt T; van der Does R; Schräder R; Landgraf H; Kober G J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930 [TBL] [Abstract][Full Text] [Related]